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Background: The comparatively evaluate the three surgical treatment modalities namely cryosurgery, diode and 
CO2 laser surgery in terms of healing outcomes on the day of surgery, first and second week post operatively and 
recurrence at the end of 18 months was assessed. 
Material and Methods: Thirty selected patients were divided randomly into three groups. Each group comprising of 
ten patients were subjected to one of the three modalities of treatment namely cryosurgery, diode laser or CO2 laser 
surgery for ablation of OL. Obtained data was analyzed using mainly using Chi-square and Anova tests.
Results: Study showed statistical significant differences (p > 0.05) for evaluation parameters like pain, edema and 
scar. The parameters like infection, recurrence, bleeding showed no statistical significance. Pain was significantly 
higher in CO2 laser surgery group as compared with diode laser group. There was no recurrence observed at the end 
of the 6 months follow up period in all the three study groups. 
Conclusion: Observations from the study highlights that all three surgical modalities used in this study were effec-
tive for treatment of OL, and the overall summation of the results of the study showed that laser therapy (CO2 and 
Diode) seems to offer better clinically significant results than cryotherapy. 
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Introduction
Oral cancer is one of the commonest of all cancers in In-
dia and only 10% are non-tobacco related (1). Oral leu-
koplakia (OL), a commonly found oral lesion, precedes 
oral cancer development in certain section of people (2). 
This precancerous white lesion poses a significant risk of 
malignant transformation and the rate ranges from 0.13 
% to 34% (3). It is one among the common premalignant 
lesions of the oral mucosa and tobacco is the usual no-
table etiological factor (4). The risk of malignant trans-
formation of OL is difficult to assess as suggested by 
Napier and Speight who reviewed clinical factors like 
age, sex, location and type of lesion responsible for the 
malignant transformation of OL and found that the result 
varied in different studies (5). It is a premalignant lesion 
usually associated with tobacco usage and other factors 
being betel nut chewing and alcohol consumption (6). 
The first line in the management of OL is elimination of 
contributory factors like smoking,  tobacco usage , quit-
ting betel quid, and reduction or complete withdrawal of 
alcohol usage. Complete cessation of tobacco can have 
substantial implication on prognosis (7). The line of 
treatment is also based on the lesion severity including its 
site, size, and location with any associated dysplasia (8). 
OL is managed by various modalities of treatment both 
medical and surgical. The goal of OL is to reverse or to-
tally eradicate the changes which has happened in the 
oral mucosa. OL is treated through the medical line of 
management with varied success, both topically and sys-
temically, and it includes agents like vitamin A and re-
tinoid, systemic beta-carotene, lycopene, ketorolac local 
bleomycin (9). Although vitamin A or retinoid, have been 
used as a medical line of management little scientific evi-
dence exists for their use with regard to reducing rate of 
recurrence and its malignant transformation rates (10).
Various surgical treatment modalities for OL manage-
ment have been advocated and it includes conventional 
surgery, cryotherapy and laser surgery (8,11). Conventio-
nal surgeries are limited by site and extent of the lesion. 
Cryosurgery is simple, safe, time tested and an effec-
tive modality of treatment for OL and also for treating 
certain benign and pre-cancer oral cavity lesions. Lasers 
provide a bundle of options over conventional surgery as 
they provide advantage of precision excision, homeos-
tasis, reduced postoperative swelling and pain (12,13). 
This study was designed to investigate the efficacy and 
compare the sequel of healing and recurrence pattern of 
three surgical modalities – Cryosurgery, CO2 laser, and 
Diode Laser surgery in treating OL.
Material and Methods
Thirty outpatients visiting the Department of Oral and 
Maxillofacial Surgery of Dayananda Sagar College of 
Dental Sciences, Bangalore, who presented with persis-
tent white lesion six weeks’ status post habit cessation 
and with a biopsy result positive for OL were enrolled 
for the study. An informed written consent was secured 
from all patients and advantages and disadvantages of 
surgery were explained. Patients were subjected to blood 
investigations including complete hemogram, random 
blood sugar, bleeding time, clotting time. This clinical 
study was endorsed by the ethical panel or the institutio-
nal review board. Those patients with OL that regressed 
in size following habit cessation and those patients with 
active malignancy were excluded from the study. The 
study group comprised of 20 men and 10 women with a 
mean age of  36 years.
Total of three groups was formed by dividing thirty pa-
tients randomly with each group consisting of ten pa-
tients. Each group was subjected to one of the three di-
fferent treatment modes. Group, I patients were treated 
using a diode laser, Group II patients were treated using 
CO2 laser and Group III was treated using  nitrous oxi-
de cryosurgery. All the patients were evaluated using a 
questionnaire to obtain past medical, surgical, and dental 
history and Intra and extra oral examination was perfor-
med. Two percent Lignocaine with epinephrine 1:80,000 
was infiltrated into the surgical area as local anesthetic 
agent for all groups.
In Group I: A 970 nm diode laser system with 4 watts was 
used in a continuous mode under local anesthesia. The 
leukoplakic lesions were identified and limits of the le-
sion were marked using a surgical marker. The treatment 
was performed in contact mode until lesion was comple-
tely ablated (Fig. 1). In Group II: A CO2 laser was used 
to perform surgery by a wavelength beam of 10.6 μm. 
The power output was maintained in the usual standard 
range of 5 - 15 watt on pulsed/continuous mode, while 
the aiming beam with a spot size of 1mm (standard) was 
used. The tissue to be ablated was initially marked with 
a margin of about 3mm in a pulsed mode and the abla-
tion was performed in a non-contact mode by moving a 
slightly defocused spot of CO2 laser on the lesion until 
complete evaporation and it reached sub-mucosa (Fig. 
2). In Group III: The cryosurgery procedure was per-
formed by direct application of nitrous oxide cryoprobe 
at a temperature of -65◦ to -85◦ C. The cryoprobe was 
applied for around 45-60 seconds following ice ball for-
mation and the tissue was allowed to thaw completely 
prior to reapplication of the probe. The cryoprobe was 
applied for at least two or three freeze-thaw cycles. The 
probe was successively applied over adjacent sites and a 
spatial overlap consisting of rapid frozen areas were pro-
duced. Several applications by mapping technique were 
necessary to treat large lesions (Fig. 3).
All patients of the three groups Group 1 (diode laser), 
Group II (CO2 laser) Group III (cryosurgery) were as-
sessed for bleeding and pain on the day of the surgery. 
Evaluation for pain was done with the help of a Visual 
analog scale (with the extremes having values 0 and 10, 
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Fig. 2: CO2 laser varorization. B1) Pre operative lesion. B2) Post operative. B3) 6 months Post operative.
Fig. 3: Cryosurgery. C1) Intra operative. C2) Post operative. C3) 6 months Post operative.
Fig. 1: Diode laser surgery. A1) Pre operative lesion. A2) Post operative. A3) 6 months Post operative.
with 0 corresponding to ‘no pain’ and 10 corresponding 
to ‘maximum pain imaginable’). Bleeding was assessed 
by noting the presence or absence of spontaneous bleed. 
Edema was evaluated by comparing the wound area with 
the anatomical area of the opposite side for presence or 
absence of asymmetry while infection, scar formation 
and slough were evaluated based on inspection alone.
The follow-up visits were in the first and second posto-
perative week and pain, edema, slough formation and 
infection were assessed. Scar formation and lesion re-
currence was evaluated at three and six months posto-
peratively. No intra and postoperative complications or 
infections were noted subsequently.  
-Statistical Analysis
The frequency distribution was expressed in terms of 
number and percentage for categorical variables (each 
study parameter) to be compared among three groups. 
Chi-Square test was used to compare the distribution / as-
sociation of the study variables between the three groups 
at each time interval. The mean and standard deviation 
(SD) was obtained for the pain scores and was compared 
between the groups using one-way ANOVA test followed 
by Tukey’s HSD test as the Post hoc analysis. The level of 
significance (P-Value) was set at P<0.05.
All participants have read and signed informed consent 
form. The use of human subjects in this study has been 
reviewed and approved by the Dayananda Sagar Institu-
tion ethical committee Review Board.
Results
Pain in the three study groups was compared on the day 
of surgery, first and second week postoperatively using 
ANOVA test. On the day of the surgery, the pain was 
more in the cryosurgery group (mean-2.3±0.5) which 
was statistically significant when compared with the 
other two groups.
When the pain score was further compared among CO2 
laser group and cryosurgery group, on the day of the sur-
gery, a statistically significant P-value of 0.03 was obtai-
ned. In the second week, post-operative comparison of 
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pain score among the three groups showed a significant 
statistical score (P-value of <0.001). Cryosurgery group 
showed a higher pain score (1.2 ± 0.6) whereas diode 
laser group showed 100% absence of pain (Table 1).
The presence of edema among the three groups in the 
first and second postoperative week was analyzed using 
chi-square test. Edema was recorded in 40% of the par-
ticipants of cryosurgery group in the first week, whereas 
in CO2 and Diode laser surgery groups no edema was 
recorded. A statistically significant  P- the value of 0.01 
was elicited for the first week. However, in the second 
week no edema was seen in all three groups (Table 2).
Scar formation was observed in 30% of the participants 
in the Cryosurgery group whereas there was no scar for-
mation in both CO2 laser and Diode laser groups, in the ? ?
Time Groups N Mean SD Std. Error Min Max F P-value Diff P-Value 
Day of Surgery Laser 10 1.6 0.5 0.2 1 2 4.5 0.02* L Vs C 0.03* 
 Cryo 10 2.3 0.5 0.2 2 3   L Vs D 0.92 
 Diode 10 1.7 0.7 0.2 1 3   C VS D 0.06 
1 Week Laser 10 1.4 0.5 0.2 1 2 1.773 0.19 .. .. 
 Cryo 10 1.7 0.5 0.2 1 2     
 Diode 10 1.3 0.5 0.2 1 2     
2 Weeks Laser 10 0.9 0.6 0.2 0 2 16.2 <0.001* L Vs C 0.37 
 Cryo 10 1.2 0.6 0.2 1 3   L Vs D 0.001* 
 Diode 10 0 0 0 0 0   C VS D <0.001* 
Table 1: Comparison among the three study groups during Post-op periods using Chi square test.
third postoperative month. A statistically significant P-
value of   0.04 was thus recorded. In the sixth month, 
the absence of scar formation among all the three groups 
was noted (Table 2).
Discussion
It is an accepted fact that it is indeed a challenge to the 
clinician to treat OL. It is a potentially pre-malignant 
lesion with high recurrence capacity and different me-
thods both medical and surgical are employed for its 
management. Clinical studies done with medical line 
of  management to treat OL have reported high relap-
se rate with variable side effect severity (14). However, 
though many clinical studies have been done to evaluate 
the efficacy of surgical management of OL  there are 
no studies reported comparing the three modalities like 
cryotherapy, Diode laser  and CO2 laser surgery for its 
effectiveness in treatment of OL . Ideally, any treatment 
mode must be aimed at being safe, effective minimally 
invasive, with reduced recurrence or relapse.
Different surgical options have been successfully used 
for the management of OL lesions which include cryo-
therapy, diode laser, or CO2 laser (8,11,15).  Sako et al. 
have reported complete regression of the lesions using 
cryotherapy on sixty  patients with OL (16). Chin-Jyh 
Yeh performed cryosurgical treatment on 102 benign 
oral lesions in which there was no intra operative, or 
postoperative bleeding, no surgical defects, minimum 
scarring, and no infection following treatment (17). Cr-
yotherapy is estimated by authors as a simple, safe, easy, 
and acceptable treatment modality. Another optimal and 
safe treatment option in the surgical management of OL 
is laser surgery.  Ben-Bassat et al, first used laser surgery 
for treatment of OL in 1978 (18). Two types of lasers are 
used for surgical excision namely diode laser and CO2 
laser. Diode laser surgery is well accepted by patients 
and is an effective mode of treatment due to its bio-sti-
mulating effect which brings about excellent healing and 
low morbidity (19). The CO2 laser allows vaporization 
and excision as well as restitution of diseased tissue and 
provides satisfactory results with low complication rates 
(20).  
In our study, a comparative assessment of cryosurgery, 
diode laser and CO2 laser surgery in the treatment of OL 
was performed. All the three modalities can be perfor-
med with relative ease and comfort for the patient with 
minimal use of local anesthesia. As per our study. CO2 
and diode laser exhibited significantly better clinical pa-
rameters when compared with cryosurgery in the mana-
gement of leukoplakia. The parameters that were used 
for evaluating patients were pain, edema and slough 
formation. This finding is in accordance with clinical 
studies recorded in literature (21-24) which states that 
minimal pain in a post- operative period of laser surgery 
is due to its effect on nerve endings; reduced the ther-
mal damage to surrounding tissue, and sealing of small 
lymphatic vessels leading to reduced postoperative pain 
and edema.
Goharkhay et al.  in their study showed that the diode 
laser is a very effective because of its excellent coagula-
tion ability (24). In our study, there was a total absence 















n % n % n % 
Edema 1 Week Absent 10 1050% 6 60% 10 100% 9.231 0.01* 
Present 0 0% 4 40% 0 0% 
2 Week Absent 10 100% 10 100% 10 100% .. .. 
Present 0 0% 0 0% 0 0% 
Infection 1 Week Absent 10 100% 8 80% 10 100% 4.286 0.12 
Present 0 0% 2 20% 0 0% 
2 Week Absent 10 100% 8 80% 10 100% 4.286 0.12 
Present 0 0% 2 20% 0 0% 
Bleeding Day of 
Surgery 
 
Absent 9 90% 10 100% 8 80% 2.222 0.33 
Present 1 10% 0 0% 2 20% 
Scar 3 Months Absent 10 100% 7 70% 10 100% 6.667 0.04* 
Present 0 0% 3 30% 0 0% 
6 Months Absent 10 100% 10 100% 10 100% .. .. 
Present 0 0% 0 0% 0 0% 
Slough First 
Week 
Absent 10 100% 10 100% 10 100% .. .. 
Present 0 0% 0 0% 0 0% 
Second
Week 
Absent 10 100% 10 100% 10 100% .. .. 
Present 0 0% 0 0% 0 0% 
Recurrence 3 Months 
 
Absent 10 100% 10 100% 10 100% .. .. 
Present 0 0% 0 0% 0 0% 
6 Months 
 
Absent 10 100% 10 100% 10 100% .. .. 
Present 0 0% 0 0% 0 0% 
Table 2: Comparison of Mean Pain score between 03 groups using One-way ANOVA followed by Tukey’s Post hoc Analysis.
of bleeding in cryosurgery group while CO2 and diode 
laser surgery groups showed clinically negligible blee-
ding tendencies. Our observation showed that less ther-
mal damage to the tissues adjacent to the site of injury 
following the use of diode and CO2 laser. Wound healing 
after laser surgery at all times was slightly accelerated 
compared to cryosurgery. Although sloughing was ob-
served on the second day after cryosurgery it was absent 
when reviewed on the first-week postoperatively. Slo-
ugh was observed in the first few days that could act as a 
physical barrier causing delayed wound healing. Overall 
healing followed a comparable time course as there did 
not appear to be much difference in the rate of repair at 
the end of the second week. Laser surgery resulted in 
better wound healing, less contraction, and scarring due 
to the reduction in the number of myofibroblasts, even in 
cases of large area of ablation (25).
Scar formation which was seen in patients treated with 
cryosurgery was totally absent in laser surgery treated 
groups. However, this scar (following Cryosurgery) sett-
led and disappeared at the end of 6 months postoperati-
vely.
The observations of our study indicated that even though 
all three surgical modalities used in this study were 
effective for treatment of leukoplakia, CO2 and diode 
lasers proved to be a better option in terms of reduced 
pain intensity, infection, and scar formation.  In terms 
of pain; diode laser proved to be more effective than 
CO2 laser treatment. After a follow-up of 6 months in 
all the three study groups, no recurrence was found. The 
longest follow-up was after 24 months in cryosurgery 
group, 18 months for CO2 laser group and 12 months for 
diode laser group. Although the ability of surgical mana-
gement has not been assessed using randomized clinical 
trials, in its role in the prevention of recurrent OL and 
subsequent malignant transformation, this paper has to 
an extent addressed quantitatively what was achieved by 
surgical treatment and its prognosis.
Conclusions
We conclude that the overall summation of the results 
of the study showed that laser therapy (CO2 and Diode) 
offered better clinically significant results than cryothe-
rapy in the management of OL. However, as the study 
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group was small and follow-up period was limited, long-
term, multicentre randomized, controlled clinical trials 
are needed to substantiate the efficacy of different surgi-
cal methods for treating OL, with emphasis on preven-
tion of recurrence and malignant transformation.
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